Who can use Lotemax(loteprednol etabonat)?

OPDUALAG is approved for treating unresectable or metastatic melanoma.

Approved Use

This medication is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. The approval is based on clinical trial data demonstrating a statistically significant improvement in progression-free survival compared to nivolumab monotherapy. Its use is specific to this patient population and this stage of the disease.